Kobayashi Masahiro, Japanese Film Director of Bashing, The Rebirth, Dies at 68

Publish date: 2024-07-26

Kobayashi Masahiro, the director of four films that screened at Cannes, died in Tokyo on August 20, 2022, age 68. His death was disclosed only on Wednesday, with the cause given as colonic cancer.  

Born in Tokyo in 1954, Kobayashi started out as a folksinger and scriptwriter for television and erotic features called ‘pink films.’  

In 1996, at age 42, he made his directorial debut with “Closing Time,” a self-financed indie about the life and loves of an alcoholic scriptwriter. The film won the grand prize at the first Yubari International Fantastic Film Festival.  

Related Stories

Downward line graph with an Apple Vision Pro on fire VIP+

Apple Vision Pro Clouds the Bright Future for XR

Kay Scarpetta cast Amazon

Amazon Greenlights Kay Scarpetta Series Starring Nicole Kidman and Jamie Lee Curtis, Adds Five Cast Members

His next films screened three years in a row at Cannes – “Kaizokuban Bootleg Film” (1999) and “Man Walking on Snow” (2001) in Un Certain Regard and “Koroshi” (2000) in the Directors’ Fortnight.  

Popular on Variety

Among his biggest critical successes, however, was “Bashing,” a 2005 drama about a young woman who goes to Iraq to provide humanitarian aid, is kidnapped and released. When she returns to her provincial hometown, she is brutally bullied for ‘selfishly’ causing trouble. Screened in competition at Cannes, the film went on to win several awards, including a Grand Prize at Tokyo Filmex.    

Kobayashi also garnered international kudos for “The Rebirth,” a dark drama about the father of a murdered girl and the mother of the killer who reunite at a countryside inn. Premiering at Locarno in 2007, the film won the Golden Leopard and three other prizes. It played widely on the festival circuit.  

In 2017 Kobayashi released his last film, “Lear on the Shore,” a drama starring Japanese screen icon Nakadai Tatsuya as a dementia-afflicted man. Around the same Kobayashi was reportedly diagnosed with colon cancer and spent much time in his remaining years in treatment.

Read More About:

Jump to Comments

More from Variety

Most Popular

Must Read

Sign Up for Variety Newsletters

By providing your information, you agree to our Terms of Use and our Privacy Policy.We use vendors that may also process your information to help provide our services. // This site is protected by reCAPTCHA Enterprise and the Google Privacy Policy and Terms of Service apply.

Variety Confidential

ncG1vNJzZmiukae2psDYZ5qopV9nfXN%2Bjp%2BgpaVfo7K4v46kppuZqZbAqbWMppismZiev7B5w56YnWWUnrK0ecmap5qmlaiybrLIpaRmnJmnsqTAzqtkampjaoB3fpVxbWg%3D